Mon panier

Human CEACAM-6 / CD66c Protein, Fc Tag, low endotoxin (MALS verified)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
CE6-H5254-100ug
$360.00
CE6-H5254-1mg
$2380.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Synonyms

    CEACAM6, CD66c, CEAL, NCA

  • Source

    Human CEACAM-6, Fc Tag (CE6-H5254) is expressed from human 293 cells (HEK293). It contains AA Lys 35 - Gly 320 (Accession # P40199-1).

    Predicted N-terminus: Lys 35

    Request for sequence
  • Molecular Characterization

    CEACAM-6 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a human IgG1 Fc tag at the C-terminus.

    The protein has a calculated MW of 57.7 kDa. The protein migrates as 75-90 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SDS-PAGE

    CEACAM-6 SDS-PAGE

    Human CEACAM-6, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

  • SEC-MALS

    CEACAM-6 SEC-MALS

    The purity of Human CEACAM-6, Fc Tag (Cat. No. CE6-H5254) is more than 95% and the molecular weight of this protein is around 165-195 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     CEACAM-6 ELISA

    Immobilized Human CEACAM-8, His Tag (Cat. No. CE8-H5224) at 5 μg/mL (100 μL/well) can bind Human CEACAM-6, Fc Tag (Cat. No. CE6-H5254) with a linear range of 0.01-0.156 μg/mL (QC tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

FAQ

  • Product

    Are there any studies showing that CEACAM6 and CEACAM8 can interact?

    Yes. According to the reference “Diverse oligomeric states of CEACAM IgV domains” (PNAS), CEACAMs can form homophilic and/or heterophilic interactions (e.g., CEACAM6–CEACAM8, CEACAM5–CEACAM6). Structural studies of the CEACAM6–CEACAM8 heterodimer showed that the addition of CEACAM8 to CEACAM6 led to heterodimer formation, confirming their ability to bind each other.

Introduction de fond

Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) (CEACAM6) is also known as CD66c (Cluster of Differentiation 66c), CEAL, NCA, and is one of seven human CEACAM family members within the immunoglobulin superfamily. In humans, CEACAMs include type I transmembrane proteins (CEACAM1, CEACAM3, and CEACAM4) and GPI-linked molecules (CEACAM5 through CEACAM8). There is no human CEACAM2. CEACAM 6 contains one N-terminal V-type Ig-like domain (N domain), followed by two C2-type Ig-like domains. It shows considerable glycosylation, including (sialyl) LewisX, which mediates binding to E-selectin, galectins and some bacterial fimbrae. CEACAM-6 is expressed by granulocytes and their progenitors. It is also expressed by epithelia of various organs and is upregulated in pancreatic and colon adenocarcinomas, as well as hyperplastic polyps. Resistance to adhesion-related apoptosis in tumor cells is conferred in the condition of CEACAM6 overexpression.

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Carcinoembryonic antigen related cell adhesion molecule 6

  • Catégorie:

  • Nombre de médicaments répertoriés:

    0 Détails

  • Nombre de médicaments cliniques:

    3 Détails

  • Étape de développement la plus élevée:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • FAQ
  • Contexte